This study [contRAst 1 (201790: NCT03980483)] is a phase 3, randomized, multicenter, double blind study to assess the safety and...
The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis...
Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.
This open-label, single arm study will evaluate the efficacy and safety of subcutaneously administered RoActemra/Actemra (tocilizumab), in monotherapy or in...
This study will compare the plasma pharmacokinetic profile and the change in disease activity score in patients with active rheumatoid...
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in...
This is a randomized, double-blinded, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of tildrakizumab compared to placebo...
This study [contRAst 2 (201791: NCT03970837)] is a phase 3, randomized, multicenter, double blind study to assess the safety and...
This research will help doctors interested in the usefulness of a new test to discover hidden tuberculosis infections in patients...
The purpose of the study is to evaluate how safe, how effective and how well tolerated, the study drug Olokizumab...
Study to evaluate the safety and effectiveness of treatment with branebrutinib treatment in participants with active systemic Lupus Erythematosus (SLE)...
An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of RemsimaTM in Patients with Rheumatoid Arthritis.
The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain...
The multicenter, randomized controlled trial is to investigate and evaluate the effect of NSAIDs therapy on recurrence in patients with...
The purpose of this two-part study is to assess the efficacy, safety and tolerability of multiple intra-articular (i.a.) injections of...
This study is the first administration of GSK3858279 in humans and will be conducted in two parts: Part A will...
The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein...
This is a Phase 1, open-label, 3-period, single-sequence, crossover study to evaluate potential effects of olokizumab on pharmacokinetics (PK) of...
This is a Phase 3, Multicenter, 22-Week, double-blind and 30-Week open label Study to Evaluate the Efficacy and Safety of...
This is a Phase 3, Multicenter, Randomized, 22 Week, Double-Blind, Placebo Controlled and 3-Week, Open-Label Study to Evaluate the Efficacy...
English (USA)